DocWire News Editors

DocwireNews

Researchers have recently used artificial intelligence (AI) to better predict outcomes in patients with severe malaria. In their study, quantitative analysis showed features that predicted not only the magnitude of each patient&rsquo;s outcome, but the dynamic pathways of malaria progression as well. These pathways ultimately allowed the team to find each patient&rsquo;s individual risk of mortality. This work was recently published in <a href="https://www.nature.com/articles/s41746-019-0140-y">npj Digital Medicine</a>.<h2>Malaria&rsquo;s Threat to Public Health</h2><a href="https://www.docwirenews.com/abstracts/precision-identification-of-high-risk-phenotypes-and-progression-pathways-in-severe-malaria-without-requiring-longitudinal-data/">Malaria</a> presents as a considerable threat to public health, with 3.3 billion people living in regions where the disease is transmitted through mosquitoes. 445,000 deaths were reported from an estimated 216 million cases of malaria in 2016, with most of these fatalities occurring in sub-Saharan Africa. Identification of severe malaria is intended to target children at the highest risk of death, such as those with cerebral malaria or respiratory distress. It is particularly challenging to identify these individuals, however, and current patient outcomes are failing to improve.With prevalent data regarding malaria patient outcomes and advances in technologies like machine learning AI, this UK research team saw an opportunity to better understand the dynamics malaria. The scientists used mutual information (MI) to learn clinical factors that predict patient outcomes and an algorithm that learned the dynamic pathways of the disease progression. The authors note that this dual approach is not specific to malaria and that it can be applied to the study of any disease progression.<h2>Background of the Study</h2>The dataset was comprised of 2,915 children aged 4 months to 15 years who meet the WHO criteria for severe malaria. These patients were admitted to the Royal Victoria Teaching Hospital (RVTH) in Banjul, The Gambia between 1997 and 2009. From this set, 2,904 children were used with available outcome data, with 387 of these patients dying (case-fatality rate: 13.3%). The researchers divided the children into 3 different categories based on features of disease severity: respiratory distress (40.2%), cerebral malaria (36.5%), and severe anemia (22.7%).The team then used their algorithm to reveal the features most strongly correlated with increased risks of mortality. They found that cerebral malaria was the strongest predictor of mortality in the patient cohort. After splitting the cohort into cerebral vs. noncerebral malaria cases, they found respiratory distress to be the second strongest predictor. Further analysis showed abnormal posturing, absence of transfusion and lack of splenomegaly to be tightly correlated to mortality as well.The researchers also surveyed 11 clinical practitioners in the malaria field to compare to their algorithm&rsquo;s predictions. These predictions were found to be significantly correlated to the computational ones from the dataset. These survey results correlated better with the inferred results of living patients, rather than those who died.This dual usage of mutual information and machine learning algorithms allowed these researchers to identify the most informative clinical features that correlate with death in children with severe malaria, as well as the sequence of appearance of these features. This was made possible through the analysis of many patient samples together and putting them all in one framework for disease progression.&ldquo;The value of this powerful approach is clear: we can simultaneously learn the dynamic pathways of disease progression, identify key predictors of clinical outcome, and use this unprecedented elucidation of disease dynamics to facilitate novel and clinically informative classification of the clinical risk associated with individual patients,&rdquo; the authors concluded.

Jordana Jampel

Positive Preliminary Results From Phase 1 Trial of Dopaminergic Neuron Graft for Parkinson’s Disease

Dementia

Bradley Warady, MD

Joel M. Topf, MD, FACP

2025 Hume Award Winner Is Dedicated to Children’s Care

NKF Spring Clinical Meetings 2025

Distant Brain Metastases in Cutaneous Melanoma May Be Mitigated With Multiple Pathway Inhibitors

Melanoma

Latest News

Machine Learning Used to Predict Malaria Outcomes

Researchers have recently used artificial intelligence (AI) to better predict outcomes in patients with severe malaria. In their study, quantitative analysis showed features ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe